Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
The Oncologist|March 27, 2023
Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned ResectionBenoît Allignet, Paul Pou, Floriane Izarn, et al.
Scientific Reports|December 22, 2017
A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and OutcomePauline Rochefort, Antoine Italiano, Valérie Laurence, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2023
Prognostic factors and outcomes of adult spermatic cord sarcoma. A study from the French Sarcoma GroupGilles Achard, Céline Charon-Barra, Sebastien Carrere, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
Modified posterior pelvic exenteration for ovarian cancerGilles Houvenaeghel, Martin Gutowski, Max Buttarelli, et al.
BMC Health Services Research|January 6, 2018
Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of FranceMarius Huguet, Lionel Perrier, Olivia Bally, et al.
Bulletin Du Cancer|March 30, 2012
Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organizationPatrick Castel, Louis Tassy, Antoine Lurkin, et al.
Personalized Medicine|May 2, 2018
A comparison of Australian and French families affected by sarcoma: perceptions of genetics and incidental findingsVictoria Rasmussen, Laura E Forrest, Muriel Rogasik, et al.
Cancer Research|June 24, 2011
Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancerSana Intidhar Labidi-Galy, Vanja Sisirak, Pierre Meeus, et al.
Bulletin Du Cancer|March 29, 2023
[Endometrial stromal sarcoma: French Guidelines from the French Sarcoma Group and the Rare Malignant Gynecologic Tumors Group]Coriolan Lebreton, Pierre Meeus, Catherine Genestie, et al.
Bulletin Du Cancer|September 10, 2025
[Understanding biology to identify new therapeutic targets beyond chemotherapy in ovarian granulosa cell tumors]Sil Endale Ahanda, Alexandra Lainé, Brunhilde Hanvic, et al.
Pageof 9